Head & Neck Cancer

The investigational agent tipifarnib shows promise in patients with head and neck cancer who have a certain gene mutation.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Jason Mendelsohn, a stage 4 HPV-related throat cancer survivor who created a web site geared to raising awareness about HPV-related cancers.

Poison’s Rikki Rockett discusses the immunotherapy clinical trial that led him into remission.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a caregiver about support for others taking care of a loved one with cancer through a letter she wrote to her younger self.

The Food and Drug Administration has approved Keytruda for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus in certain patients.

From Beth Chapman’s untimely passing to cancer fundraising via esports, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Keytruda monotherapy and in combination with chemotherapy for the front-line treatments of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma.

From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.

Patients with head and neck cancer may soon have more effective, less toxic choices as immunotherapy moves into first-line treatment and novel targeted drugs are explored.

Compared with the general population, men and women with type 2 diabetes face greater risk of developing certain cancers, such as colorectal, kidney, liver and more.

This essay was written by Maria Campos nominating Mary Kernan, RN, OCN, of Smilow Cancer Center At Yale New Haven Health, New Haven, Connecticut, for CURE®'s Extraordinary Healer® Award.

Here are the top 5 CURE stories for April 2019.

Use of two medicated mouthwashes reduced pain from oral mucositis during the first four hours after administration; however, the results were not deemed clinically different when compared with placebo.

In this Special Edition of CURE Talks Cancer, we chat with Poison drummer and throat cancer survivor Rikki Rockett about his cancer journey and why it's important to "Open Up and Say... Ahh!" during Oral, Head and Neck Cancer Awareness Week.

From artificial intelligence to a surprise FDA resignation, check out this week’s quick overview of what is making headlines in the cancer space.

A five-year lesson in cancer, worry and hope.

The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

A recent meta-analysis has found no noticeable difference in immunotherapy’s efficacy based on patient sex.

Survivor diagnosed with second cancer after surgeon spots a lump on her throat while watching TV.

Immunotherapy may lead to a major change in how the treatment of metastatic recurrent head and neck cancer is approached, according to Barbara Burtness, M.D., a professor of medicine at Yale School of Medicine.

Despite associated toxicities, cisplatin chemotherapy induced superior efficacy compared with a new alternative among patients with HPV-positive oropharyngeal carcinoma.

The FDA has granted an accelerated approval to larotrectinib for the treatment of adult and pediatric patients with solid tumors that have an NTRK gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment.

Patients who received chemotherapy, actively smoked and drank alcohol, and were diagnosed with head and neck cancer reported significantly higher rates of opiate use, according to study results presented at the American Society of Clinical Oncology (ASCO) 2018 Palliative and Supportive Care Symposium.

SCOTT WIESKAMP KNEW THE spot on his tonsil wasn’t normal.